DOCSLIB.ORG

Pathway Entry Into the T Lymphocyte Developmental Molecular Dissection of Prethymic Progenitor

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pathway Entry Into the T Lymphocyte Developmental Molecular Dissection of Prethymic Progenitor The Journal of Immunology Molecular Dissection of Prethymic Progenitor Entry into the T Lymphocyte Developmental Pathway1 C. Chace Tydell,2 Elizabeth-Sharon David-Fung,2,3 Jonathan E. Moore, Lee Rowen,4 Tom Taghon,5 and Ellen V. Rothenberg6 Notch signaling activates T lineage differentiation from hemopoietic progenitors, but relatively few regulators that initiate this program have been identified, e.g., GATA3 and T cell factor-1 (TCF-1) (gene name Tcf7). To identify additional regulators of T cell specification, a cDNA library from mouse Pro-T cells was screened for genes that are specifically up-regulated in intrathymic T cell precursors as compared with myeloid progenitors. Over 90 genes of interest were iden- tified, and 35 of 44 tested were confirmed to be more highly expressed in T lineage precursors relative to precursors of B and/or myeloid lineage. To a remarkable extent, however, expression of these T lineage-enriched genes, including zinc finger transcription factor, helicase, and signaling adaptor genes, was also shared by stem cells (Lin؊Sca-1؉Kit؉CD27؊) and multipotent progenitors (Lin؊Sca-1؉Kit؉CD27؉), although down-regulated in other lineages. Thus, a major fraction of these early T lineage genes are a regulatory legacy from stem cells. The few genes sharply up-regulated between multipotent progenitors and Pro-T cell stages included those encoding transcription factors Bcl11b, TCF-1 (Tcf7), and HEBalt, Notch target Deltex1, Deltex3L, Fkbp5, Eva1, and Tmem131. Like GATA3 and Deltex1, Bcl11b, Fkbp5, and Eva1 were dependent on Notch/Delta signaling for induction in fetal liver precursors, but only Bcl11b and HEBalt were up-regulated between the first two stages of intrathymic T cell development (double negative 1 and double negative 2) corresponding to T lineage specification. Bcl11b was uniquely T lineage restricted and induced by Notch/Delta signaling specifically upon entry into the T lineage differentiation pathway. The Journal of Immunology, 2007, 179: 421–438. he circulating population of mature T lymphocytes is con- cell type, loss of the transcription factor causes a selective block of stantly regenerated as hemopoietic progenitors leave the the developmental pathway while gain of function of the transcrip- T bone marrow (BM)7 and home to the thymus where de- tion factor can accelerate differentiation into the lineage. Equiva- velopment and maturation occur (1–3). Cell-intrinsic regulatory lent “master regulators” of T cell development have not yet been factors that are up-regulated in a lineage-specific way play domi- found. More than eight known transcription factors are essential nant roles in lineage choice of hemopoietic precursors. In RBC for T cell development (reviewed in Refs. 4 and 5), but none of development, GATA1 acts as a central mediator of erythroid gene these exhibits the ability to instruct or accelerate entry into the T expression, and it is known that B cells are instructed specifically cell program. by early B cell transcription factor and Pax5. These transcription Two transitions in early T cell development are of particular factors can be considered “master regulators” because, for each interest for lineage choice mechanisms: the onset of T lineage gene expression (“specification”), and the final exclusion of any fate except a T cell fate (“commitment”). Both transitions occur among Division of Biology, California Institute of Technology, Pasadena, CA 91125 intrathymic, early T lineage cell populations (Pro-T cells), which Received for publication December 18, 2006. Accepted for publication April are still negative for the mature T cell markers CD4 and CD8 and 16, 2007. do not yet express TCRs. These double-negative (DN) cells within The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance the mouse thymus are divided into four stages on the basis of their with 18 U.S.C. Section 1734 solely to indicate this fact. expression of the surface markers Kit, CD25, and CD44 reviewed 1 This work was supported by grants (to E.V.R.) from the National Science Founda- in Refs. 6–8. The first thymocyte population, DN1, maintains tion (MCB-9983129) and National Institutes of Health U.S. Public Health Service much lineage plasticity and, under special conditions, is capable of (R01 CA90233 and R01 CA98925), by National Institutes of Health U.S. Public Health Service awards K08 AI054699 (to C.C.T.) and F32 AI068366 (to J.E.M.); and producing macrophages, NK cells, or dendritic cells, with a minute from the DNA Sequencer Royalty Fund at the California Institute of Technology. subset apparently capable of generating B cells as well (9–12). It 2 C.C.T. and E.-S.D.-F. contributed equally to this study. is not yet clear whether DN1 cells are distinct from prethymic 3 Current address: Theoretical Division, Los Alamos National Laboratory, Los precursors in gene expression pattern. However, as cells enter the Alamos, NM 87544. next stage, DN2, they express sharply increased levels of Pro-T 4 Current address: Institute for Systems Biology, Seattle, WA 98103. cell genes such as those encoding pT␣, CD3␧, CD25, Rag1, and 5 Current address: Department of Clinical Chemistry, Microbiology and Immunology, IL-7R␣ (CD127) (10, 13–16), and some rearrangement begins at University Hospital Ghent, Ghent University, Ghent, Belgium. the DJ␤ and VJ␥ TCR loci (17, 18). In hemopoietic precursors 6 Address correspondence and reprint requests to Dr. Ellen V. Rothenberg, Division of Biology 156-29, California Institute of Technology, Pasadena, CA 91125. E-mail (derived from fetal liver) that are differentiating in vitro in re- address: [email protected] sponse to Notch/Delta signaling, the first-appearing DN2 pheno- 7 Abbreviations used in this paper: BM, bone marrow; DN, double negative; Dtx3L, type cells display the same dramatic increase in expression of these Deltex3-like; pT␣, pre-TCR␣; qRT-PCR, quantitative real-time PCR; TCF-1, T cell genes (19). DN2 cells have undergone “specification” but are not factor-1. yet committed to the T lymphocyte pathway; a high proportion of Copyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00 DN2 cells are still able to differentiate into NK cells, macrophages, www.jimmunol.org 422 GENE DISCOVERY FOR T CELL SPECIFICATION IN VIVO AND IN VITRO or dendritic cells (10, 20–23). At the DN3 stage, thymocytes stop Thymus and BM samples were taken from animals 5–7 wk old. The dividing, further increase expression of the Pro-T differentiation animals used were bred and maintained under sterile conditions at Caltech. genes as well as Notch target genes (24), and undergo extensive cDNA library TCR rearrangements. Only at this stage do they become committed to a T cell fate in vivo. Cells only progress beyond the DN3 stage The C.B-17-scid thymocyte, random-primed, cDNA library was con- through successful TCR gene rearrangement and TCR-dependent structed in the pSPORT1 vector (Invitrogen Life Technologies), and was arrayed and spotted at high density onto Hybond-Nϩ nylon filters selection, at which time they graduate from Pro-T cell status, to (Amersham Biosciences) using the Q-BOT robot (Genetix) as described give rise to up to five types of T cells: ␣␤ CD4, ␣␤ CD8, ␥␦, NKT, previously (31). or regulatory T cells. Of all these developmental transitions, surprisingly little is Cell populations for library generation and library screening known about the stages encompassing “T lineage specification,” The two types of cells used as sources of RNA for the subtraction protocol that is, the DN1 to DN2 transition. The regulatory participants in were a bulk population of Pro-T cells and a population of progenitor/ these early stages have not been sufficiently characterized to ex- premyeloid cells. To obtain large numbers of Pro-T cells in the DN1-DN3 plain the outcome, although Notch/Delta signaling plays a role (19, stages, we took advantage of the Rag2 knockout mouse, in which thymo- cyte development arrests at DN3. In the wild-type mouse thymus, DN3 25). Traditional methods to identify all the transcription factors cells account for only 1% of thymocytes, but even without sorting, Rag2 that play key roles in early stages of T lineage specification have knockout thymocytes consist of 90% DN3 Pro-T cells, with the remaining found limited success, in part because transcription factors are typ- cells being DN1, DN2, NK, or thymic stromal cells. Because these cells were not pure Pro-T cells, we refer to them in the text as “Pro-T plus.” A ically present in low copy numbers. T cell precursors at the earliest Ϫ ϩ stages are represented in vivo at any one time by tiny numbers of progenitor/premyeloid population was obtained from Lin Kit BM cells matured in culture toward a myeloid fate. Specifically, BM cells that were cells, providing very limiting material for standard microarray KitϩGr1ϪCD11bϪTer119ϪCD19Ϫ from Rag2ko mice were cultured for analysis. In addition, small fold changes in transcription factor 42 h at 37°C in 5% CO2 in IMDM with 10% heat-inactivated FCS sup- abundance or changes in transcription factor ratios may generate plemented with IL-3 (100 ␮l of WEHI-3B cell supernatant/ml medium), stem ␮ dramatic shifts in cell state. Identification of truly novel regulatory cell factor (Kit ligand) (100 l of BHK-MKL cell supernatant/ml medium), and 10 ng/ml rIL-6 (PeproTech). At the time of harvest, the morphological factors and novel isoforms of known factors has also been limited appearance of the cells ranged from undifferentiated, blast-like cells to mature by the comprehensiveness of the microarrays used (26–29) and by granulocytes. the microarray’s nucleotide probe design. To circumvent these problems, we used a subtractive hybrid- Cell populations for quantitative RNA expression analysis ization technique (30) to probe a mouse Pro-T cell cDNA mac- In addition to the subtraction populations, sorted cell populations were roarray library.
Load more

Recommended publications
  • Microdeletions in 16P11.2 and 13Q31.3 Associated with Developmental Delay and Generalized Overgrowth
    Microdeletions in 16p11.2 and 13q31.3 associated with developmental delay and generalized overgrowth A.M. George1, J. Taylor2 and D.R. Love1 1Diagnostic Genetics, LabPlus, Auckland City Hospital, Auckland, New Zealand 2Northern Regional Genetic Service, Auckland City Hospital, Auckland, New Zealand Corresponding author: D.R. Love E-mail: [email protected] Genet. Mol. Res. 11 (3): 3133-3137 (2012) Received November 28, 2011 Accepted July 18, 2012 Published September 3, 2012 DOI http://dx.doi.org/10.4238/2012.September.3.1 ABSTRACT. Chromosome microarray analysis of patients with developmental delay has provided evidence of small deletions or duplications associated with this clinical phenotype. In this context, a 7.1- to 8.7-Mb interstitial deletion of chromosome 16 is well documented, but within this interval a rare 200-kb deletion has recently been defined that appears to be associated with obesity, or developmental delay together with overgrowth. We report a patient carrying this rare deletion, who falls into the latter clinical category, but who also carries a second very rare deletion in 13q31.3. It remains unclear if this maternally inherited deletion acts as a second copy number variation leading to pathogenic variation, or is non-causal and the true modifiers are yet to be determined. Key words: Developmental delay; Obesity; Overgrowth; GPC5; SH2B1 Genetics and Molecular Research 11 (3): 3133-3137 (2012) ©FUNPEC-RP www.funpecrp.com.br A.M. George et al. 3134 INTRODUCTION Current referrals for chromosome microarray analysis (CMA) are primarily for de- termining the molecular basis of developmental delay and autistic spectrum disorder in child- hood.
    [Show full text]
  • Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma
    Anatomy and Pathology Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma Sarah L. Lake,1 Sarah E. Coupland,1 Azzam F. G. Taktak,2 and Bertil E. Damato3 PURPOSE. To detect deletions and loss of heterozygosity of disease is fatal in 92% of patients within 2 years of diagnosis. chromosome 3 in a rare subset of fatal, disomy 3 uveal mela- Clinical and histopathologic risk factors for UM metastasis noma (UM), undetectable by fluorescence in situ hybridization include large basal tumor diameter (LBD), ciliary body involve- (FISH). ment, epithelioid cytomorphology, extracellular matrix peri- ϩ ETHODS odic acid-Schiff-positive (PAS ) loops, and high mitotic M . Multiplex ligation-dependent probe amplification 3,4 5 (MLPA) with the P027 UM assay was performed on formalin- count. Prescher et al. showed that a nonrandom genetic fixed, paraffin-embedded (FFPE) whole tumor sections from 19 change, monosomy 3, correlates strongly with metastatic death, and the correlation has since been confirmed by several disomy 3 metastasizing UMs. Whole-genome microarray analy- 3,6–10 ses using a single-nucleotide polymorphism microarray (aSNP) groups. Consequently, fluorescence in situ hybridization were performed on frozen tissue samples from four fatal dis- (FISH) detection of chromosome 3 using a centromeric probe omy 3 metastasizing UMs and three disomy 3 tumors with Ͼ5 became routine practice for UM prognostication; however, 5% years’ metastasis-free survival. to 20% of disomy 3 UM patients unexpectedly develop metas- tases.11 Attempts have therefore been made to identify the RESULTS. Two metastasizing UMs that had been classified as minimal region(s) of deletion on chromosome 3.12–15 Despite disomy 3 by FISH analysis of a small tumor sample were found these studies, little progress has been made in defining the key on MLPA analysis to show monosomy 3.
    [Show full text]
  • Bayesian Hierarchical Modeling of High-Throughput Genomic Data with Applications to Cancer Bioinformatics and Stem Cell Differentiation
    BAYESIAN HIERARCHICAL MODELING OF HIGH-THROUGHPUT GENOMIC DATA WITH APPLICATIONS TO CANCER BIOINFORMATICS AND STEM CELL DIFFERENTIATION by Keegan D. Korthauer A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Statistics) at the UNIVERSITY OF WISCONSIN–MADISON 2015 Date of final oral examination: 05/04/15 The dissertation is approved by the following members of the Final Oral Committee: Christina Kendziorski, Professor, Biostatistics and Medical Informatics Michael A. Newton, Professor, Statistics Sunduz Kele¸s,Professor, Biostatistics and Medical Informatics Sijian Wang, Associate Professor, Biostatistics and Medical Informatics Michael N. Gould, Professor, Oncology © Copyright by Keegan D. Korthauer 2015 All Rights Reserved i in memory of my grandparents Ma and Pa FL Grandma and John ii ACKNOWLEDGMENTS First and foremost, I am deeply grateful to my thesis advisor Christina Kendziorski for her invaluable advice, enthusiastic support, and unending patience throughout my time at UW-Madison. She has provided sound wisdom on everything from methodological principles to the intricacies of academic research. I especially appreciate that she has always encouraged me to eke out my own path and I attribute a great deal of credit to her for the successes I have achieved thus far. I also owe special thanks to my committee member Professor Michael Newton, who guided me through one of my first collaborative research experiences and has continued to provide key advice on my thesis research. I am also indebted to the other members of my thesis committee, Professor Sunduz Kele¸s,Professor Sijian Wang, and Professor Michael Gould, whose valuable comments, questions, and suggestions have greatly improved this dissertation.
    [Show full text]
  • The HECT Domain Ubiquitin Ligase HUWE1 Targets Unassembled Soluble Proteins for Degradation
    OPEN Citation: Cell Discovery (2016) 2, 16040; doi:10.1038/celldisc.2016.40 ARTICLE www.nature.com/celldisc The HECT domain ubiquitin ligase HUWE1 targets unassembled soluble proteins for degradation Yue Xu1, D Eric Anderson2, Yihong Ye1 1Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2Advanced Mass Spectrometry Core Facility, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA In eukaryotes, many proteins function in multi-subunit complexes that require proper assembly. To maintain complex stoichiometry, cells use the endoplasmic reticulum-associated degradation system to degrade unassembled membrane subunits, but how unassembled soluble proteins are eliminated is undefined. Here we show that degradation of unassembled soluble proteins (referred to as unassembled soluble protein degradation, USPD) requires the ubiquitin selective chaperone p97, its co-factor nuclear protein localization protein 4 (Npl4), and the proteasome. At the ubiquitin ligase level, the previously identified protein quality control ligase UBR1 (ubiquitin protein ligase E3 component n-recognin 1) and the related enzymes only process a subset of unassembled soluble proteins. We identify the homologous to the E6-AP carboxyl terminus (homologous to the E6-AP carboxyl terminus) domain-containing protein HUWE1 as a ubiquitin ligase for substrates bearing unshielded, hydrophobic segments. We used a stable isotope labeling with amino acids-based proteomic approach to identify endogenous HUWE1 substrates. Interestingly, many HUWE1 substrates form multi-protein com- plexes that function in the nucleus although HUWE1 itself is cytoplasmically localized. Inhibition of nuclear entry enhances HUWE1-mediated ubiquitination and degradation, suggesting that USPD occurs primarily in the cytoplasm.
    [Show full text]
  • Mouse Germ Line Mutations Due to Retrotransposon Insertions Liane Gagnier1, Victoria P
    Gagnier et al. Mobile DNA (2019) 10:15 https://doi.org/10.1186/s13100-019-0157-4 REVIEW Open Access Mouse germ line mutations due to retrotransposon insertions Liane Gagnier1, Victoria P. Belancio2 and Dixie L. Mager1* Abstract Transposable element (TE) insertions are responsible for a significant fraction of spontaneous germ line mutations reported in inbred mouse strains. This major contribution of TEs to the mutational landscape in mouse contrasts with the situation in human, where their relative contribution as germ line insertional mutagens is much lower. In this focussed review, we provide comprehensive lists of TE-induced mouse mutations, discuss the different TE types involved in these insertional mutations and elaborate on particularly interesting cases. We also discuss differences and similarities between the mutational role of TEs in mice and humans. Keywords: Endogenous retroviruses, Long terminal repeats, Long interspersed elements, Short interspersed elements, Germ line mutation, Inbred mice, Insertional mutagenesis, Transcriptional interference Background promoter and polyadenylation motifs and often a splice The mouse and human genomes harbor similar types of donor site [10, 11]. Sequences of full-length ERVs can TEs that have been discussed in many reviews, to which encode gag, pol and sometimes env, although groups of we refer the reader for more in depth and general infor- LTR retrotransposons with little or no retroviral hom- mation [1–9]. In general, both human and mouse con- ology also exist [6–9]. While not the subject of this re- tain ancient families of DNA transposons, none view, ERV LTRs can often act as cellular enhancers or currently active, which comprise 1–3% of these genomes promoters, creating chimeric transcripts with genes, and as well as many families or groups of retrotransposons, have been implicated in other regulatory functions [11– which have caused all the TE insertional mutations in 13].
    [Show full text]
  • Ubiquitination Is Not Omnipresent in Myeloid Leukemia Ramesh C
    Editorials Ubiquitination is not omnipresent in myeloid leukemia Ramesh C. Nayak1 and Jose A. Cancelas1,2 1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center and 2Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH, USA E-mail: JOSE A. CANCELAS - [email protected] / [email protected] doi:10.3324/haematol.2019.224162 hronic myelogenous leukemia (CML) is a clonal tination of target proteins through their cognate E3 ubiq- biphasic hematopoietic disorder most frequently uitin ligases belonging to three different families (RING, Ccaused by the expression of the BCR-ABL fusion HERCT, RING-between-RING or RBR type E3).7 protein. The expression of BCR-ABL fusion protein with The ubiquitin conjugating enzymes including UBE2N constitutive and elevated tyrosine kinase activity is suffi- (UBC13) and UBE2C are over-expressed in a myriad of cient to induce transformation of hematopoietic stem tumors such as breast, pancreas, colon, prostate, lym- cells (HSC) and the development of CML.1 Despite the phoma, and ovarian carcinomas.8 Higher expression of introduction of tyrosine kinase inhibitors (TKI), the dis- UBE2A is associated with poor prognosis of hepatocellu- ease may progress from a manageable chronic phase to a lar cancer.9 In leukemia, bone marrow (BM) cells from clinically challenging blast crisis phase with a poor prog- pediatric acute lymphoblastic patients show higher levels nosis,2 in which myeloid or lymphoid blasts fail to differ- of UBE2Q2
    [Show full text]
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • AFF3 Upregulation Mediates Tamoxifen Resistance in Breast
    Shi et al. Journal of Experimental & Clinical Cancer Research (2018) 37:254 https://doi.org/10.1186/s13046-018-0928-7 RESEARCH Open Access AFF3 upregulation mediates tamoxifen resistance in breast cancers Yawei Shi1†, Yang Zhao2†, Yunjian Zhang1, NiJiati AiErken3, Nan Shao1, Runyi Ye1, Ying Lin1* and Shenming Wang1* Abstract Background: Although tamoxifen is a highly effective drug for treating estrogen receptor–positive (ER+) breast cancer, nearly all patients with metastasis with initially responsive tumors eventually relapse, and die from acquired drug resistance. Unfortunately, few molecular mediators of tamoxifen resistance have been described. Here, we describe AFF3 (AF4/FMR2 family member 3), which encodes a nuclear protein with transactivation potential that confers tamoxifen resistance and enables estrogen-independent growth. Methods: We investigated AFF3 expression in breast cancer cells and in clinical breast cancer specimens with western blot and Real-time PCR. We also examined the effects of AFF3 knockdown and overexpression on breast cancer cells using luciferase, tetrazolium, colony formation, and anchorage-independent growth assays in vitro and with nude mouse xenografting in vivo. Results: AFF3 was overexpressed in tamoxifen-resistant tumors. AFF3 overexpression in breast cancer cells resulted in tamoxifen resistance, whereas RNA interference–mediated gene knockdown reversed this phenotype. Furthermore, AFF3 upregulation led to estrogen-independent growth in the xenograft assays. Mechanistic investigations revealed that AFF3 overexpression activated the ER signaling pathway and transcriptionally upregulated a subset of ER-regulated genes. Clinical analysis showed that increased AFF3 expression in ER+ breast tumors was associated with worse overall survival. Conclusions: These studies establish AFF3 as a key mediator of estrogen-independent growth and tamoxifen resistance and as a potential novel diagnostic and therapeutic target.
    [Show full text]
  • Proteomic Analysis of the Rad18 Interaction Network in DT40 – a Chicken B Cell Line
    Proteomic analysis of the Rad18 interaction network in DT40 – a chicken B cell line Thesis submitted for the degree of Doctor of Natural Sciences at the Faculty of Biology, Ludwig-Maximilians-University Munich 15th January, 2009 Submitted by Sushmita Gowri Sreekumar Chennai, India Completed at the Helmholtz Zentrum München German Research Center for Environmental Health Institute of Clinical Molecular Biology and Tumor Genetics, Munich Examiners: PD Dr. Berit Jungnickel Prof. Heinrich Leonhardt Prof. Friederike Eckardt-Schupp Prof. Harry MacWilliams Date of Examination: 16th June 2009 To my Parents, Sister, Brother & Rajesh Table of Contents 1. SUMMARY ........................................................................................................................ 1 2. INTRODUCTION ............................................................................................................. 2 2.1. MECHANISMS OF DNA REPAIR ......................................................................................... 3 2.2. ADAPTIVE GENETIC ALTERATIONS – AN ADVANTAGE ....................................................... 5 2.3. THE PRIMARY IG DIVERSIFICATION DURING EARLY B CELL DEVELOPMENT ...................... 6 2.4. THE SECONDARY IG DIVERSIFICATION PROCESSES IN THE GERMINAL CENTER .................. 7 2.4.1. Processing of AID induced DNA lesions during adaptive immunity .................. 9 2.5. TARGETING OF SOMATIC HYPERMUTATION TO THE IG LOCI ............................................ 10 2.6. ROLE OF THE RAD6 PATHWAY IN IG DIVERSIFICATION
    [Show full text]
  • Autism Multiplex Family with 16P11.2P12.2 Microduplication Syndrome in Monozygotic Twins and Distal 16P11.2 Deletion in Their Brother
    European Journal of Human Genetics (2012) 20, 540–546 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Autism multiplex family with 16p11.2p12.2 microduplication syndrome in monozygotic twins and distal 16p11.2 deletion in their brother Anne-Claude Tabet1,2,3,4, Marion Pilorge2,3,4, Richard Delorme5,6,Fre´de´rique Amsellem5,6, Jean-Marc Pinard7, Marion Leboyer6,8,9, Alain Verloes10, Brigitte Benzacken1,11,12 and Catalina Betancur*,2,3,4 The pericentromeric region of chromosome 16p is rich in segmental duplications that predispose to rearrangements through non-allelic homologous recombination. Several recurrent copy number variations have been described recently in chromosome 16p. 16p11.2 rearrangements (29.5–30.1 Mb) are associated with autism, intellectual disability (ID) and other neurodevelopmental disorders. Another recognizable but less common microdeletion syndrome in 16p11.2p12.2 (21.4 to 28.5–30.1 Mb) has been described in six individuals with ID, whereas apparently reciprocal duplications, studied by standard cytogenetic and fluorescence in situ hybridization techniques, have been reported in three patients with autism spectrum disorders. Here, we report a multiplex family with three boys affected with autism, including two monozygotic twins carrying a de novo 16p11.2p12.2 duplication of 8.95 Mb (21.28–30.23 Mb) characterized by single-nucleotide polymorphism array, encompassing both the 16p11.2 and 16p11.2p12.2 regions. The twins exhibited autism, severe ID, and dysmorphic features, including a triangular face, deep-set eyes, large and prominent nasal bridge, and tall, slender build. The eldest brother presented with autism, mild ID, early-onset obesity and normal craniofacial features, and carried a smaller, overlapping 16p11.2 microdeletion of 847 kb (28.40–29.25 Mb), inherited from his apparently healthy father.
    [Show full text]
  • The Results of an X-Chromosome Exome Sequencing Study
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2015-009537 on 29 April 2016. Downloaded from HUWE1 mutations in Juberg-Marsidi and Brooks syndromes: the results of an X-chromosome exome sequencing study Michael J Friez,1 Susan Sklower Brooks,2 Roger E Stevenson,1 Michael Field,3 Monica J Basehore,1 Lesley C Adès,4 Courtney Sebold,5 Stephen McGee,1 Samantha Saxon,1 Cindy Skinner,1 Maria E Craig,4 Lucy Murray,3 Richard J Simensen,1 Ying Yzu Yap,6 Marie A Shaw,6 Alison Gardner,6 Mark Corbett,6 Raman Kumar,6 Matthias Bosshard,7 Barbara van Loon,7 Patrick S Tarpey,8 Fatima Abidi,1 Jozef Gecz,6 Charles E Schwartz1 To cite: Friez MJ, Brooks SS, ABSTRACT et al Strengths and limitations of this study Stevenson RE, . HUWE1 Background: X linked intellectual disability (XLID) mutations in Juberg-Marsidi syndromes account for a substantial number of males ▪ and Brooks syndromes: the Using the power of next generation sequencing, with ID. Much progress has been made in identifying results of an X-chromosome we have linked Juberg-Marsidi syndrome ( JMS) exome sequencing study. the genetic cause in many of the syndromes described and Brooks syndrome as allelic conditions. – BMJ Open 2016;6:e009537. 20 40 years ago. Next generation sequencing (NGS) ▪ This study provides better organisation to the doi:10.1136/bmjopen-2015- has contributed to the rapid discovery of XLID genes field of X linked disorders by providing evidence 009537 and identifying novel mutations in known XLID genes that JMS is not caused by mutation in the ATRX for many of these syndromes.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]